Cargando…

Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle

Low priority of disease prevention and health promotion in medical education may contribute to lack of lifestyle-counseling in clinical practice. Pharmacology-related knowledge is valued 5 times higher compared to lifestyle-related knowledge in examinations on noncommunicable diseases (NCDs) in unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Krachler, B., Jerdén, L., Tönnesen, H., Lindén, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227799/
https://www.ncbi.nlm.nih.gov/pubmed/34194960
http://dx.doi.org/10.1016/j.pmedr.2021.101453
_version_ 1783712608132530176
author Krachler, B.
Jerdén, L.
Tönnesen, H.
Lindén, C.
author_facet Krachler, B.
Jerdén, L.
Tönnesen, H.
Lindén, C.
author_sort Krachler, B.
collection PubMed
description Low priority of disease prevention and health promotion in medical education may contribute to lack of lifestyle-counseling in clinical practice. Pharmacology-related knowledge is valued 5 times higher compared to lifestyle-related knowledge in examinations on noncommunicable diseases (NCDs) in undergraduate medical education in Sweden. This study aims to establish (i) whether medical licensing examinations are biased to favor pharmacology- over lifestyle-related knowledge and (ii) whether such a bias is present in both Sweden and the US. We identified 204 NCD-related questions from previous Swedish licensing examinations, and 77 cases from a U.S. question bank commonly used to prepare for the United States Medical Licensing Examination® (USMLE®) Step 3. With the help of expected correct answers, we determined distribution of points attainable for knowledge in the respective category (lifestyle / pharmacology / other) for 5 major NCDs: coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), diabetes, hypertension, and stroke. The percentage of points attainable for lifestyle-related knowledge was 6.7 (95% CI 4.1–9.3) in Sweden and 4.6 (95%CI 0.0–9.1) in the U.S. The respective percentages for pharmacology-related knowledge were 32.6 (95% CI 26.3–38.8) and 44.5 (95% CI 33.2–55.8) percent. The pharmacology vs. lifestyle-quotas were 4.9 in Sweden and 9.8 in the U.S. Likelihoods of equal emphasis on lifestyle and pharmacology in NCDs was < 0.001 in both countries. There is a marked preference for pharmacology over lifestyle in medical licensing examinations in both Sweden and the U.S. Newly qualified doctors may be inadequately prepared to address preventable causes of NCDs.
format Online
Article
Text
id pubmed-8227799
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-82277992021-06-29 Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle Krachler, B. Jerdén, L. Tönnesen, H. Lindén, C. Prev Med Rep Regular Article Low priority of disease prevention and health promotion in medical education may contribute to lack of lifestyle-counseling in clinical practice. Pharmacology-related knowledge is valued 5 times higher compared to lifestyle-related knowledge in examinations on noncommunicable diseases (NCDs) in undergraduate medical education in Sweden. This study aims to establish (i) whether medical licensing examinations are biased to favor pharmacology- over lifestyle-related knowledge and (ii) whether such a bias is present in both Sweden and the US. We identified 204 NCD-related questions from previous Swedish licensing examinations, and 77 cases from a U.S. question bank commonly used to prepare for the United States Medical Licensing Examination® (USMLE®) Step 3. With the help of expected correct answers, we determined distribution of points attainable for knowledge in the respective category (lifestyle / pharmacology / other) for 5 major NCDs: coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), diabetes, hypertension, and stroke. The percentage of points attainable for lifestyle-related knowledge was 6.7 (95% CI 4.1–9.3) in Sweden and 4.6 (95%CI 0.0–9.1) in the U.S. The respective percentages for pharmacology-related knowledge were 32.6 (95% CI 26.3–38.8) and 44.5 (95% CI 33.2–55.8) percent. The pharmacology vs. lifestyle-quotas were 4.9 in Sweden and 9.8 in the U.S. Likelihoods of equal emphasis on lifestyle and pharmacology in NCDs was < 0.001 in both countries. There is a marked preference for pharmacology over lifestyle in medical licensing examinations in both Sweden and the U.S. Newly qualified doctors may be inadequately prepared to address preventable causes of NCDs. 2021-06-17 /pmc/articles/PMC8227799/ /pubmed/34194960 http://dx.doi.org/10.1016/j.pmedr.2021.101453 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular Article
Krachler, B.
Jerdén, L.
Tönnesen, H.
Lindén, C.
Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title_full Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title_fullStr Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title_full_unstemmed Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title_short Medical licensing examinations in both Sweden and the US favor pharmacology over lifestyle
title_sort medical licensing examinations in both sweden and the us favor pharmacology over lifestyle
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227799/
https://www.ncbi.nlm.nih.gov/pubmed/34194960
http://dx.doi.org/10.1016/j.pmedr.2021.101453
work_keys_str_mv AT krachlerb medicallicensingexaminationsinbothswedenandtheusfavorpharmacologyoverlifestyle
AT jerdenl medicallicensingexaminationsinbothswedenandtheusfavorpharmacologyoverlifestyle
AT tonnesenh medicallicensingexaminationsinbothswedenandtheusfavorpharmacologyoverlifestyle
AT lindenc medicallicensingexaminationsinbothswedenandtheusfavorpharmacologyoverlifestyle